The Benefit of an Umbrella Protocol: Reducing Challenges in Orthopedic Oncology Research
- PMID: 38541777
- PMCID: PMC10971551
- DOI: 10.3390/jcm13061551
The Benefit of an Umbrella Protocol: Reducing Challenges in Orthopedic Oncology Research
Abstract
Background: Orthopedic oncology research is hindered by the scarcity of musculoskeletal tumors and research administrative inefficiencies. This paper introduces observational research through an innovative institution-specific methodology-termed an umbrella protocol. This protocol outlines a comprehensive standard procedure to expedite ethical approval for future aligned studies, reducing administrative barriers to research. Methods: We developed an umbrella protocol at an academic center, involving meticulous methodological identification and coordination with the institutional review board (IRB) to adhere to local guidelines. The protocol encompasses identifying investigators, research objectives, study goals, and data and safety monitoring frameworks necessary for typical standards. Results: Implementation of the umbrella protocol took 110 days to achieve exemption status, following multiple discussions with the IRB and extensive revisions. At the authors institution, this protocol significantly reduces protocol review times from an average of six-to-eight weeks to nearly instantaneous, facilitating a streamlined research process. Additionally, we established a dedicated orthopedic oncology patient registry to enhance future research endeavors. Conclusions: The adoption of umbrella protocols represents a pioneering strategy in orthopedic oncology. This approach mitigates research administrative burdens and broadens research scope in the field. It underscores the necessity of IRB collaboration, methodological precision, and stringent data management. The article also reflects on the ethical implications and potential biases introduced by emerging technologies like artificial intelligence, advocating for diligent ethical oversight. The establishment of an umbrella protocol marks a significant step towards more efficient research methodologies, ultimately aiming to improve patient care and outcomes for individuals with rare musculoskeletal conditions.
Keywords: oncologic research; orthopedic oncology; rare disease research; research challenges.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
American Society of Clinical Oncology policy statement: oversight of clinical research.J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29. J Clin Oncol. 2003. PMID: 12721281
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Customizable orthopaedic oncology implants: one institution's experience with meeting current IRB and FDA requirements.Springerplus. 2016 Jul 4;5(1):967. doi: 10.1186/s40064-016-2696-1. eCollection 2016. Springerplus. 2016. PMID: 27429877 Free PMC article.
-
Ethical standards for medical research in the Israeli military - review of the changes in the last decade.Isr J Health Policy Res. 2016 Dec 1;5:53. doi: 10.1186/s13584-016-0113-4. eCollection 2016. Isr J Health Policy Res. 2016. PMID: 27980720 Free PMC article. Review.
-
Design and analysis of umbrella trials: Where do we stand?Front Med (Lausanne). 2022 Oct 12;9:1037439. doi: 10.3389/fmed.2022.1037439. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36313987 Free PMC article.